Anti-interleukin-6 receptor monoclonal antibody (Biocad)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-interleukin-6 receptor monoclonal antibody (Biocad)
Drug Alias NameAnti IL-6R MAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIL-6 receptor antagonists
TargetsInterleukin-6IL-6 receptor
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBIOCAD JSC
China Registration ClassN/A

Develop Information

Active CompaniesBIOCAD JSC
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A